ZYPREXA
As listed in the register: ZYPREXA
5 mg · tablet
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Olanzapine
- Made by
- Cheplapharm Registration Gmbh
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Olanzapine). It describes the substance, not this exact product.
The mechanism of action of olanzapine, in the listed indications is unclear.
However, the efficacy of olanzapine in schizophrenia could be mediated through a combination of dopamine and serotonin type 2 (5HT 2 ) antagonism.
It is eliminated extensively by first pass metabolism, with approximately 40% of the dose metabolized before reaching the systemic circulation.
Specific Populations Renal Impairment — Because olanzapine is highly metabolized before excretion and only 7% of the drug is excreted unchanged, renal dysfunction alone is unlikely to have a major impact on the pharmacokinetics of olanzapine.
Food does not affect the rate or extent of olanzapine absorption.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-08
Safety of the active substance
From the US prescribing label for the same active substance (Olanzapine). It describes the substance, not this exact product.
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.
- None with olanzapine tablets monotherapy..
- When using olanzapine and fluoxetine in combination, also refer to the Contraindications section of the package insert for Symbyax..
- For specific information about the contraindications of lithium or valproate, refer to the Contraindications section of the package inserts for these other products..
- None with olanzapine monotherapy.
Most common adverse reactions (≥5% and at least twice that for placebo) associated with: Oral Olanzapine Monotherapy: Schizophrenia (Adults) – postural hypotension, constipation, weight gain, dizziness, personality disorder, akathisia.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States40 matching products
European UnionNo exact match for this strength and form
Spain69 matching products
- ZYPREXA 5 mg · comprimido8 makers
- ZYPREXA VELOTAB 5 mg · comprimido bucodispersable6 makers
- OLANZAPINA ALTER 5 mg · comprimido bucodispersable2 makers
- OLANZAPINA APOTEX 5 mg · comprimido bucodispersable2 makers
- OLANZAPINA AUROVITAS 5 mg · comprimido bucodispersable2 makers
- OLANZAPINA COMBIX 5 mg · comprimido bucodispersable2 makers
- OLANZAPINA KRKA 5 mg · comprimido bucodispersable2 makers
- OLANZAPINA MABO 5 mg · comprimido bucodispersable2 makers
France26 matching products
- OLANZAPINE ARROW 5 mg · comprimé2 makers
- OLANZAPINE BIOGARAN 5 mg · comprimé enrobé2 makers
- OLANZAPINE CRISTERS 5 mg · comprimé enrobé2 makers
- OLANZAPINE EG 5 mg · comprimé orodispersible2 makers
- OLANZAPINE EVOLUGEN 5 mg · comprimé orodispersible2 makers
- OLANZAPINE SANDOZ 5 mg · comprimé orodispersible2 makers
- OLANZAPINE TEVA 5 mg · comprimé orodispersible2 makers
- OLANZAPINE VIATRIS 5 mg · comprimé orodispersible2 makers
Netherlands23 matching products
- Olanzapine SUN 5 mg orodispergeerbare tabletten 5 mg · orodispergeerbare tablet2 makers
- Olanzapine SUN 5 mg tabletten 5 mg · tablet2 makers
- Olanzapine TEVA 5 mg 5 mg · filmomhulde tablet2 makers
- Zalasta 5 mg 5 mg · tablet2 makers
- Olanzapine Accord 5 mg filmomhulde tabletten 5 mg · filmomhulde tablet
- Olanzapine Aurobindo 5 mg tabletten 5 mg · tablet
- Olanzapine Glenmark 5 mg 5 mg · tablet
- Olanzapine Glenmark Europe 5 mg orale smelttabletten 5 mg · orodispergeerbare tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Cheplapharm Registration Gmbh |
|---|---|
| Active substance | Olanzapine |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 5 mg |
| Form | tablet |
| Classification | N05AH03 · Pain, sleep, mood, epilepsy and the brain |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02229269 |
| DPD drug code | 43531 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
6 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.